Storys aus Switzerland

The International Osteoporosis Foundation (IOF)

2

IOF: A fracture every 3 seconds worldwide - That's osteoporosis

Firmenich

Firmenich Recognized as Diversity & Inclusion Leader With Ethical Corporation Responsible Business Award 2019

Geneva, Switzerland (ots/PRNewswire) - Firmenich, the world's largest privately-owned Perfume and Taste company, is proud to announce that it has been recognized for its exemplary leadership in Diversity & Inclusion with the Ethical Corporation Responsible Business Award 2019. Ethical Corporation's judges praised ...

Firmenich

Firmenich Is One of 19 Global Companies Joining Forces to Protect Biodiversity for Healthy People and a Healthy Planet

Geneva, Switzerland (ots/PRNewswire) - Firmenich, the world's largest privately-owned Perfume and Taste company, announces the launch of "One Planet Business for Biodiversity" (http://www.op2b.org/) (OP2B) at the UN Climate Action Summit in New York. A founding member of OP2B, Firmenich is one of 19 likeminded ...

Sophia Genetics

SOPHiA GENETICS Expands Executive Team With a Chief Marketing Officer and New Chief Information Officer

Lausanne, Switzerland, and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Gaëtan Fraikin and Sergei Yakneen have joined its executive team as Chief Marketing Officer and Chief Information Officer, respectively. Mr. Fraikin and Mr. Yakneen bring decades of highly ...

FDI World Dental Federation

United Nations Political Declaration on Universal Health Coverage finally has some teeth / Oral health included in global health agenda

Geneva, Switzerland (ots) - FDI World Dental Federation (FDI) welcomes the long overdue commitment to strengthening oral health in the UN Political Declaration on Universal Health Coverage (UHC) (http://ots.ch/juoOII). The declaration will be officially adopted by world leaders at the UN High-Level Meeting on UHC on ...

ROSCO

Newly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For 'Complete Clearance' of Symptoms and Consider Combination Therapy For Severe Patients

Experts also welcome upsurge in the adoption of a rosacea signs and symptoms ('phenotype') led approach in clinical practice and announce the launch of prototype clinical tools to support physicians to optimize rosacea management Lausanne, Switzerland (ots/PRNewswire) - Published online in the British Journal of ...

Debiopharm International SA

Debiopharm successfully completes randomized Phase II study for IAP antagonist Debio 1143 in high risk head & neck cancer patients

Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced positive topline results across clinical endpoints following the completion of the two-year follow-up period of its double-blind, randomized Phase II study of Debio 1143 in high-risk, previously untreated ...

Sequent Ltd.

Revolutionary automatic self-charging smart watch: Sequent - SuperCharger²

EMD - European Marketing Distribution

EMD to launch International Data Sharing

Sophia Genetics

ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial

Study to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine) in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) Lausanne, Switzerland (ots/PRNewswire) - ADC Therapeutics, an oncology drug discovery and development company that specializes in the development ...

LigneSante

LigneSante Offers a Secure Communication Platform to Revolutionize Healthcare

A community of medical professionals sharing ideas and solving problems Lausanne, Switzerland (ots/PRNewswire) - LigneSante (https://lignesante.com/) today announced their online communication platform for healthcare professionals. The desire to connect to a collective knowledge around the management of diseases, aware that very often the complexity of medical ...

Debiopharm International SA

Debiopharm and BIOASTER join forces to expand research to combat infectious diseases

Lausanne, Switzerland and Lyon, France (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, and BIOASTER (www.bioaster.org), the French Technology Research Institute in infectiology and microbiology, announced today having officialized a broad research agreement for the development of diagnostic and management innovation for infectious diseases. ...

UBS Deutschland AG

UBS Collaborates With Artist Federico Herrero to Celebrate 26 Years as Global Lead Partner of Art Basel in Basel

At the world's leading art fair, the UBS Art Collection presents a commissioned installation, painted on-site by Costa Rican artist Federico Herrero, in the UBS Lounge, as well as The UBS Art Studio (Hall 1), dedicated to #TOGETHERBAND in support of the 17 UN Global Goals "Art fairs play a pivotal role in the art ...

APR Applied Pharma Research s.a.

29th EWMA Conference: Latest Clinical Data on Nexodyn® AOS Demonstrating Higher Healing Performance in Chronic Leg Ulcers Presented by Applied Pharma Research

Balerna, Switzerland (ots/PRNewswire) - APR Applied Pharma Research sa (APR) presented at the recent 29th conference of the European Wound Management Association (EWMA) in Göteborg, the results of a clinical study confirming Nexodyn® AcidOxidizing Solution (AOS) to promote the restart of the healing process in ...

IMD

IMD World Competitiveness Ranking: Singapore topples United States as world's most competitive economy

Debiopharm International SA

Debiopharm expands its Immuno-Oncology development program for Debio 1143, with the first IAP inhibitor/nivolumab combination trial

Lausanne, Switzerland (ots) - First patient enrolled in SMARTPLUS-106, a Phase lb/II study in patients failing prior PD-1/PD-L1 treatment in selected solid tumors Debiopharm (www.debiopharm.com) announced today the first patient enrolled in SMARTPLUS-106, an exploratory study investigating the safety and efficacy of ...

Capvis AG

Capvis invests in Swiss 3D sensor and analytics company Xovis

Zollikofen and Baar, Switzerland (ots) - Capvis acquires a majority stake in Xovis, the global leader in people flow measurement and analytics. With the support of Capvis, Xovis' management will continue to focus on growth and plans to enter new markets and business segments. Capvis Equity V LP, a fund advised by the Swiss private equity firm Capvis AG ...

Galderma

#RosaceaNoFilter: Online Influencers Take the Lead in Raising Rosacea Awareness in Galderma's Empowering Rosacea Awareness Month Social Media Campaign

As part of its ongoing commitment to raising awareness of rosacea and the hidden burden of the disease, Galderma is collaborating with top social media influencers this Rosacea Awareness Month, to encourage people with rosacea to speak up and share experiences of the beyond the visible impact of living with this ...

Swiss Shakti Stiftung

Satoshi's TAKE-TWO: New blockchain protocol poised to bring digital currency to the masses

ForaCare Suisse AG

ForaCare Suisse AG Distributor, AlphaDiab, Ranked One of the Fastest Growing Companies in France

ST. GALLEN, Switzerland, (ots) - ForaCare Suisse AG (ForaCare, FORA) announced its distributor, AlphaDiab was recently named by Les Echos and Statista as one of the top fastest growing companies in France. With an average annual growth rate of 46 percent and an increase between 2014 and 2017 of 212 percent, ...

Mundipharma EDO

Mundipharma EDO GmbH: US FDA Grants Orphan Drug Designation for Tinostamustine in Very Rare Blood Cancer

FOR EX-US MEDICAL AND TRADE MEDIA ONLY - T-cell prolymphocytic leukaemia is an extremely rare and aggressive T-cell leukaemia, with very limited effective treatment options1,2 - Tinostamustine is in very early phase clinical trials to investigate it as a potential future treatment option in this area of significant ...

Primex Pharmaceuticals

Primex Pharmaceuticals and Nordic Group Sign a Strategic Partnership to Commercialise OZALIN® in France

Paris and Zug, Switzerland (ots/PRNewswire) - Nordic Group, a pharmaceutical company focusing on the development and commercialisation of hospital and orphan products, and Primex Pharmaceuticals AG, an innovative global Anaesthesia pharmaceutical company, announced a strategic agreement today to launch OZALIN® in ...

Mundipharma International

The expansion stage seeks to establish the overall response rate (ORR), duration of response (DR) and safety of five patient cohorts

Basel, Switzerland (ots/PRNewswire) - Mundipharma EDO GmbH, part of the Mundipharma global network of independent associated companies, today announced that the first patient has been enrolled in the expansion stage of a Phase I/II clinical trial of tinostamustine in patients with relapsed/refractory (R/R) ...

Capvis AG

Capvis: Change in ownership at RENA Technologies

Gütenbach, Germany and Baar, Switzerland (ots) - Capvis acquired the wet chemical activities of the South German equipment manufacturing company RENA in a challenging environment in 2015 and transferred them to the newly founded RENA Technologies GmbH. Thanks to structural and operational improvements over the last four years, RENA Technologies has ...